Assessing the impact of a safe and equitable biosimilar policy in the United States : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, May 2, 2007
(Visualizza in formato marc)
(Visualizza in BIBFRAME)
| Titolo: |
Assessing the impact of a safe and equitable biosimilar policy in the United States : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, May 2, 2007
|
| Descrizione fisica: | 1 online resource (vi, 184 p.) : ill |
| Soggetto topico: | Biologicals - United States |
| Pharmaceutical biotechnology - United States | |
| Generic drugs - United States | |
| Soggetto non controllato: | Biologicals |
| Pharmaceutical biotechnology | |
| Generic drugs | |
| Medical | |
| Technology & engineering | |
| Altri titoli varianti: | Assessing the Impact of a Safe and Equitable Biosimilar Policy in the United States |
| Titolo autorizzato: | Assessing the impact of a safe and equitable biosimilar policy in the United States |
| Formato: | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione: | Inglese |
| Record Nr.: | 9910694419603321 |
| Lo trovi qui: | Univ. Federico II |
| Opac: | Controlla la disponibilità qui |